Revenue: The sum of all revenue fields included for a company's operating activities.
GSK PLC Sponsored ADR (GSK) had Revenue of $40.10B for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
$40.10B |
$3.29B |
|
$11.56B |
|
$28.53B |
|
$34.96B |
|
$5.14B |
|
$-695.18M |
|
$4.44B |
|
$4.44B |
|
$3.77B |
|
$3.77B |
|
$3.77B |
|
$3.77B |
|
$5.14B |
|
$8.40B |
|
2.04B |
|
2.07B |
|
$1.62 |
|
$1.59 |
|
Balance Sheet Financials | |
$21.72B |
|
$11.79B |
|
$54.27B |
|
$75.99B |
|
$27.73B |
|
$18.70B |
|
$31.54B |
|
$59.27B |
|
$16.72B |
|
$-12.03B |
|
$16.72B |
|
2.16B |
|
Cash Flow Statement Financials | |
$8.38B |
|
$-1.57B |
|
$-6.04B |
|
$3.65B |
|
$4.35B |
|
$696.46M |
|
$439.60M |
|
$-3.12B |
|
-- |
|
Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
0.53 |
|
1.30 |
|
71.16% |
|
12.82% |
|
12.82% |
|
20.95% |
|
11.08% |
|
8.21% |
|
$6.67B |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
1.60 |
|
4.28 |
|
85.21 |
|
22.55% |
|
-31.36% |
|
4.96% |
|
10.64% |
|
$7.75 |
|
$3.22 |
|
$4.04 |